The histologic changes occurring in severe/therapyresistant asthma (SA) as defined by the European Respiratory Society/American Thoracic Society guidelines, particularly at the level of the distal airways are unknown. This study describes the clinical, radiologic, and histologic characteristics of 29 SA patients who underwent video-assisted thoracoscopic surgery lung biopsy. Pathologic observations were correlated with clinical features, especially the presence of autoimmune disease (AID) (15/29, 51.7%). Ten biopsies (10/29, 34.5%) showed only small airway manifestations of asthma, whereas in 19 (65.5%) asthmatic granulomatosis, manifested by asthmatic bronchiolitis supplemented by an alveolar septal mononuclear infiltrates with non-necrotizing granulomas, was present. SA patients without asthmatic granulomatosis showed more striking small airway injury, subbasement membrane thickening, and neutrophilic infiltrates. Cases with concurrent AID had a tendency to more parenchymal eosinophilic inflammation, more bronchiolocentric granulomas, and a suggestion of increased responsivity to nonsteroidal immunosuppressive therapy. Histologic examination of video-assisted thoracoscopic surgery lung biopsies in SA demonstrates diverse pathologies including cases associated with granulomatous inflammation in addition to eosinophilic infiltrates. This spectrum of histologies may link to a high incidence of AID.
A sthma is a chronic inflammatory disease manifesting as airway hyperresponsiveness and/or reversible airflow obstruction in the appropriate clinical setting. 1 Severe asthma (SA), also referred to as therapy-resistant asthma, as defined by the European Respiratory Society/ American Thoracic Society guidelines is asthma that requires high-dose inhaled/oral corticosteroids (CS) with an additional controller medication to maintain control, or that remains uncontrolled despite exhaustive therapy. 2 Classic histologic findings of asthma/SA have long been described in large airways and include mucous plugging, eosinophilic inflammation, epithelial desquamation and hyperplasia, goblet cell metaplasia, subbasement membrane thickening, subepithelial fibrosis, smooth muscle hypertrophy/hyperplasia, and submucosal gland hypertrophy. 3 Despite the clinical designation, asthma, and even SA, are not likely to be a single disease. Rather they represent a heterogenous group of patients with disparate clinical, biological, and therapeutic characteristics, 4 in whom the underlying pathology, particularly in the distal lung, remains poorly characterized.
The histopathology of asthma and SA has been reported primarily in autopsy 5 and endobronchial/transbronchial [6] [7] [8] biopsies. For this reason, the pathologic findings of asthma in the smaller airways (those smaller than 2 mm and lacking cartilage) remain largely unknown. Recently, we described a subgroup of SA patients who underwent video-assisted thoracoscopic surgery (VATS) biopsy. Specimens obtained from these VATS biopsies allowed us to gain access to the pathology of asthma at the level of the small airways and the alveolated lung parenchyma. 9 In this earlier study, we described asthmatic granulomatosis (AG), a subgroup of patients with SA whose histologic examination showed findings of asthmatic bronchiolitis with interstitial poorly formed non-necrotizing granulomas in the absence of other known causes of granulomatous lung disease. Although asthma is typically not thought of as an autoimmune disease (AID), 70% of the original cohort of AG patients demonstrated either a familial or personal history of AID. Interestingly, other conditions/comorbidities associated with SA including chronic rhinosinusitis with nasal polyps 10 and aspirin-exacerbated respiratory disease 11 have been linked to autoantibody formation.
Thoracoscopic biopsies for the diagnosis and treatment of other inflammatory lung diseases, like interstitial lung disease, are well established. However, performing thoracoscopic biopsy is not a common practice in the management of SA. We, therefore, aimed to characterize the spectrum of histologic findings in VATS lung biopsies of patients with SA, with a focus on determining whether there was a morphologic distinction between patients with and without AID.
MATERIALS AND METHODS

Study Group
Thirty-three surgical lung biopsies were obtained on patients with a clinical diagnosis of SA referred to the University of Pittsburgh Asthma Institute at the University of Pittsburgh Medical Center between 2007 and 2015. All patients met criteria for SA by the European Respiratory Society/American Thoracic Society definition, 2 and biopsy was indicated clinically due to the severity of their asthma, the lack of response to conventional asthma medication and to rule out asthma mimickers or other comorbidities. Relevant clinical and radiologic features were obtained from the medical records, including AID history. Care was taken to collect information to exclude other possible lung diseases including infection, hypersensitivity pneumonitis, sarcoidosis, immunodeficiency, and aspiration pneumonia. AID included diseases with a clinical diagnosis documented by rheumatologist or other clinician, in the setting of positive autoimmune serologies associated with functional defects. For the purpose of this study, AID also included diseases with known autoimmune physiopathology (eg, type1diabetes mellitus) and diseases with unbalanced immunity pathways leading to altered self-immunity with or without autoantibodies (eg, Crohns disease/psoriasis). 12 Some of the histologic and clinical findings of selected patients included in this study were reported elsewhere. 9 This research was approved by the University of Pittsburgh Institutional Review Board. All patients gave informed consent for additional use of their tissue and medical records for research purposes.
Pathologic and Radiologic Analysis
Wedge biopsies of lung parenchyma from at least 2 lung lobes were available for histologic examination in each patient. Each biopsy was formalin fixed and paraffin embedded and included 4 to 12 hematoxylin-eosin stain sections. Ziehl Neelsen and Gomori methenamine silver stains were performed in all cases. Microbiological cultures for aerobic and anerobic bacteria (including mycobacteria) and fungal organisms were negative in all cases. All patients had a multidetector chest computed tomography (CT) performed within 3 months of lung biopsy. CTs were reviewed by consensus by a chest radiologist (D.C.S.) and a pulmonologist (D.D.). CTs were evaluated for the presence or absence of hyperlucency, air trapping, ground glass opacities, bronchial wall thickening, and bronchiectasis.
Of the original 33 cases, 4 cases (12.1%) were excluded as the biopsies demonstrated other lung pathologies (1 case of hypersensitivity pneumonitis and 3 cases of aspiration pneumonia). The remaining 29 cases were reviewed blindly to clinical data. Histologic findings of asthma were recorded as either present or absent, focusing on their presence in the smaller airways and alveolated parenchyma. Histopathologic features assessed included mucous plugging, bronchiolectasis, subbasement membrane thickening, goblet cell metaplasia, smooth muscle hypertrophy, airspace organization, lymphoid aggregates, and presence/absence of granulomas with detailed description of their morphologic characteristics and location. Presence and location of airway and parenchyma inflammation was also recorded.
As part of the clinicopathologic analysis, cases were first segregated into those cases of SA with and without changes of AG. The cases were then further assessed for the presence or absence of clinical AID. AG was defined in a previous publication, 9 as a patient with SA with small airway histologic changes of asthma associated with alveolar septal mononuclear infiltrates and interstitial non-necrotizing granulomas, in the absence of a clinical history of hypersensitivity pneumonitis, sarcoidosis, aspiration pneumonia, or other cause for granulomatous disease. Given the small numbers of cases included in this study, formal statistics were not performed and the results are presented as descriptive analyses only.
RESULTS
Clinical Data
The clinical features of the 29 cases are summarized in Table 1 . Cases were segregated according to the morphologic presence of AG and then subsequently according to the presence of AID, into 4 groups: SA only (SA, n = 5), SA with AID (SA-AID, n = 5), SA with morphologic features of AG without AID (SA-AG, n = 9), and with AID (SA-AG-AID, n = 10). Thus, AG with or without AID was diagnosed in 19 of 29 cases (65.5%), and of these cases, 10 of 19 (52.6%), had a diagnosis of AID. The remaining cases (10/29, 34.5%) demonstrated only morphologic findings of asthma without granulomas, and of these cases, 50% had a diagnosis of AID.
For all groups, the majority of patients were female and of comparable age. SA patients had the earliest age of onset of symptoms. Most of the patients had no history of smoking. All 29 cases had physiological evidence of airflow obstruction with reduced ratio of forced expiratory volume in 1 second and forced vital capacity and forced expiratory flow, midexpiratory phase (FEF 25%-75% ) (Table 1). Extensive clinical evaluation including precipitating antibodies for hypersensitivity pneumonitis was negative.
Of the 5 cases in the SA-AID group, 1 had rheumatoid arthritis (RA), 1 had antiphospholipid syndrome, 1 had thyroid AID, 1 had Crohns disease, and 1 had type-1 diabetes mellitus. Of the 10 cases in the SA-AG-AID group, 2 had RA, 1 had systemic lupus erythematosus, 2 had an undifferentiated connective tissue disorder, 2 had antiphospholipid syndrome, 2 had thyroid AID, and 1 had psoriasis.
Chest CT scan findings are summarized in Table 1 . Air trapping was seen in all cases. Interestingly, bronchial wall thickening, a finding commonly associated with the diagnosis of asthma, 13 was observed in all patients of the SA and SA-AID groups, in 7 of 9 patients with SA-AG, but only in 3 of 6 SA-AG-AID patients. No bronchiectasis was seen in the SA-AG-AID group. Of note, no masses or consolidation were seen in any of the study patients.
After the biopsy, all patients received treatment with alternative nonsteroidal immunosuppressive or cytotoxic medications, including azathioprine, methotrexate, or anti-tumor necrosis factor-a. A positive patient response was considered as a reduction in steroid therapy, while maintaining or improving lung function (forced expiratory volume in 1 second) with fewer CS-requiring exacerbations during follow-up. Patients with SA-AID and SA-AG-AID appeared to have a better treatment response when compared with the other 2 groups (Table 1) .
Pathologic Findings
The histopathology findings in the small airways and parenchyma for each group are summarized in Table 2 . Histologic findings of asthmatic bronchiolitis with smooth muscle hypertrophy were seen in all cases (Fig. 1) . Other morphologic changes of asthma affecting the distal smaller airways were also seen, although less frequently in the AG groups. Subbasement membrane thickening was seen in all SA and SA-AID cases, but was present in fewer cases of SA-AG and SA-AG-AID (5/9 and 2/10 cases, respectively). Similarly, goblet cell metaplasia and mucus plugging were observed less often in SA-AG-AID (5/10 cases), whereas it was seen in 4 of 5 of the SA and SA-AID cases, and in 7 of 9 of the SA-AG cases.
Ill-defined, non-necrotizing granulomas composed of epithelioid histiocytes aggregates with or without giant cells and without a concentric rim of fibrosis, as seen in sarcoidosis, were observed in all AG cases (Table 2 and Fig. 2) . The non-necrotizing granulomas were mostly located in the interstitium. Airway-centered granulomas were generally more frequent in the SA-AG-AID group when compared with the SA-AG group (6/10 vs. 2/9).
Submucosal eosinophils and lymphocytes were seen in similar percentages of cases for all groups, with a tendency toward higher numbers in the SA group. In contrast, neutrophils were seen in 4 of 5 of SA cases, but only in 1 of 9 of SA-AG cases, in 2 of 5 of SA-AID and in 4 of 10 SA-AID-AG cases (Table 2 and Fig. 3 ). Similar distributions of inflammatory cells were identified in the adventitia of the small airways, again with neutrophils being less frequent in the SA-AG and SA-AG-AID groups ( Table 2) . Inflammatory infiltrates were seen in the alveolated lung parenchyma, manifesting as patchy interstitial/perivenular mononuclear cell infiltrates. Eosinophils were not found in the alveolated parenchyma of SA cases, were seen in 1 of 9 SA-AG cases, in 1 of 5 SA-AID cases, and in 3 of 10 SA-AG-AID cases (Fig. 3) . In contrast, neutrophils were not found in the alveolated parenchyma of SA-AID and SA-AG-AID groups, while they were present in 1 of 5 and in 2 of 9 of the SA and SA-AG cases, respectively. Lastly, lymphocytes were seen in the alveolated parenchyma in all groups, but were slightly more frequently found in the AG groups (with or with AID, Fig. 3 ). Small and scattered lymphoid aggregates were detected in the parenchyma in all groups, with less frequency on the SA-AG group. A minor component of airspace organization was also seen in all groups (Table 2) .
There was no evidence of mycobacterial or fungal microorganisms by Ziehl-Neelsen and Gomori methenamine silver stains, respectively. Vasculitis, necrosis, aspirated/foreign material, honeycombing, and fibroblastic foci were not identified in any of the study cases. Similarly, other findings commonly associated with involvement of the lung by a systemic AID (eg, RA, systemic lupus erythematous, etc), including pleuritis, follicular bronchiolitis/bronchitis, and constrictive bronchiolitis were not seen in any of the cases.
DISCUSSION
Asthma has long been considered a large airway disease with the small airways referred to as the "silent zone." 14, 15 Although physiological approaches to identifying asthma in the small airways suggest disease, pathologic study of this region from the lung of living asthmatics is extremely rare. Consequently, the histopathologic findings of asthma at the level of the distal airways and alveolated lung parenchyma are largely unknown, with pathologic studies based primarily on cartilaginous airway observations on transbronchial/ endobronchial biopsies and autopsy studies, often from many decades ago. 16 Here we describe the morphologic findings of the largest cohort of SA patients studied via VATS lung biopsy. We found AG in 65.5% (19/29) of SA patients, a diagnosis based on the presence of nonnecrotizing granulomas in association with traditional morphologic findings of asthma, validating the importance of this newly described disease. 9 Morphologic examination of these 29 patients with SA showed a degree of asthmatic bronchiolitis in all cases, confirming the involvement of the small airways in this group of difficult to treat asthmatics. Perhaps not surprisingly, smooth muscle hypertrophy was observed in all samples from all patients, suggesting that this morphologic finding is a sensitive pathologic feature of small airways disease in the clinical setting of asthma. However, smooth muscle hypertrophy can also be seen in other airway diseases, including chronic bronchitis, such that it cannot be considered a finding specific to asthma. 17 This increase in smooth muscle could well explain why the critical-physiological characteristic of asthma, bronchodilator reversibility/airway hyperresponsiveness was observed in all the patients. In contrast, although we found other morphologic findings of asthma in all groups, these findings were less prominent in the SA-AG groups particularly in those with AID, suggesting that together with granulomas, lack of traditional asthmatic findings might suggest the diagnosis of AG. Evaluation of tissue from more patients will be needed to determine whether this lack of remodeling features differentiates SA-AG groups from SA without AG groups. Clinically, this lack of remodeling also suggests that appropriate therapies could return lung function to normal or near normal in AG patients.
Our data support the hypothesis that SA might represent a hybrid of asthma and involvement of the lung by AID. Asthma is typically not considered an AID. However, the fact that most of our patients are middleaged females, many with coexistent clinical diagnoses of AID, suggest a novel airway-centered role of autoimmunity in a subtype of SA patients. Others have also suggested an association between autoimmunity and asthma pathophysiology, including a proposed role for antiplatelet antibodies. 18 Similarly, autoantigens have been proposed to play a role in atopic dermatitis, urticarial, and asthma, perhaps under type-1-mediated interferon-g-regulated mechanisms. 19 Recent bronchoalveolar lavage studies of SA strongly link type-1 immunity with a subset of SA patients with high levels of interferon-g. 20, 21 The prevalence of granulomatous inflammation in non-SA or in otherwise normal lungs has not been well studied. We found no granulomas in 17 adult autopsy cases with a known diagnosis of well-controlled asthma and morphologic evidence of asthmatic bronchitis who died of nonpulmonary causes. 9 Hung et al 22 studied the presence of non-neoplastic pathology in 347 lung resections for mass lesions and found granulomatous inflammation away from the lesion in only 7.8% of the cases. These data indicate that the high prevalence of nonnecrotizing granulomas in our cohort of SA cases is a distinctive histologic finding of SA.
Our study has some limitations. First, our study group is small which affects the strength of our conclusions and limits our ability to perform statistical analysis. Second, our morphologic assessment was subjective, without defined criteria for each of the histologic findings. Also, our findings might be altered by the fact that our cohort of patients had been treated with high doses of both inhaled and systemic CSs, which might affect the distribution of the inflammatory infiltrates, especially eosinophils. Lastly, in our cases of AG, we considered the possibility that the non-necrotizing granulomas were an expression of other disease, for example hypersensitivity pneumonitis, aspiration pneumonia, infections, or even the underlying AID such as RA or Crohns disease. Although some of these etiologies were excluded clinically by imaging and other laboratory studies, the possibility of "nontraditional" lung involvement by the underlying AID cannot be entirely excluded.
In summary, surgical lung biopsies in patients with clinical SA can be of clinical utility to rule out mimickers of asthma. AG is the most common finding in this cohort of SA. Thus, pathologists should be aware of this newly described disease with some of the morphologic changes of asthma but with additional ill-defined, predominantly interstitial granulomas. As of yet, there are no morphologic findings that identify coexistent AID in patients with SA. The specificity of parenchymal eosinophils and bronchiolocentric granulomas requires further investigation in larger numbers of biopsies to confirm statistical differences. Similar to interstitial lung disease, we propose that SA should have a clinical-radiologic-pathologic approach to management, as some pathologic subgroups (with coexistent AID) seem to have better response to immunosuppressive therapy (SA-AID and SA-AG-AID).
